Ignite Creation Date:
2024-05-06 @ 7:43 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02580279
Status:
UNKNOWN
Last Update Posted:
2019-04-05
First Post:
2015-09-27
Brief Title:
Study of Epigallocatechin-3-gallate EGCG for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
Sponsor:
Organization:
Shandong Cancer Hospital and Institute
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
68
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: